(Q68801487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

W Hoffmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

B Weidmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

F Migeod

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

J Könner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

S Seeber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

26 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

S69-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer.

27 September 2019

cites work

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2347053

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ifosfamide--pharmacology, safety and therapeutic potential

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2347053

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2347053

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00685425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2347053%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference